343 related articles for article (PubMed ID: 34062295)
1. Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
Deng S; Zheng Y; Mo Y; Xu X; Li Y; Zhang Y; Liu J; Chen J; Tian Y; Ke Y
World Neurosurg; 2021 Aug; 152():e436-e448. PubMed ID: 34062295
[TBL] [Abstract][Full Text] [Related]
2. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
3. Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma.
Jiang J; Duan R; Zhu J; Yan J; Ye J; Luo C
Neuromolecular Med; 2024 May; 26(1):21. PubMed ID: 38750318
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma.
Chen H; Xu C; Yu Q; Zhong C; Peng Y; Chen J; Chen G
J Cell Physiol; 2021 Apr; 236(4):2988-3000. PubMed ID: 32964440
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
[TBL] [Abstract][Full Text] [Related]
6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
7. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-147a Targets SLC40A1 to Induce Ferroptosis in Human Glioblastoma.
Xu P; Ge FH; Li WX; Xu Z; Wang XL; Shen JL; Xu AB; Hao RR
Anal Cell Pathol (Amst); 2022; 2022():2843990. PubMed ID: 35942174
[TBL] [Abstract][Full Text] [Related]
9. Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma.
Wang X; Zhang H; Zhang M; Zhang X; Mao W; Gao M
BMC Cancer; 2023 May; 23(1):415. PubMed ID: 37158834
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
Fei Z; Lijuan Y; Jing Z; Xi Y; Yuefen P; Shuwen H
Hum Cell; 2021 Jan; 34(1):177-186. PubMed ID: 32936424
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
[TBL] [Abstract][Full Text] [Related]
12. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
[TBL] [Abstract][Full Text] [Related]
13. Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.
Müller I; Altherr D; Eyrich M; Flesch B; Friedmann KS; Ketter R; Oertel J; Schwarz EC; Technau A; Urbschat S; Eichler H
Cytotherapy; 2016 Sep; 18(9):1146-61. PubMed ID: 27424145
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.
Zhang G; Hu J; Li A; Zhang H; Guo Z; Li X; You Z; Wang Y; Jing Z
Phytomedicine; 2024 Jul; 129():155631. PubMed ID: 38640858
[TBL] [Abstract][Full Text] [Related]
15. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
17. Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion.
Huan R; Zhang J; Yue J; Yang S; Han G; Cheng Y; Tan Y
J Cell Mol Med; 2024 May; 28(9):e18318. PubMed ID: 38685674
[TBL] [Abstract][Full Text] [Related]
18. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
20. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
Jia D; Li S; Li D; Xue H; Yang D; Liu Y
Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
